Principal Financial Group Inc. reduced its stake in shares of Clarivate Plc (NYSE:CLVT – Free Report) by 10.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,084 shares of the company’s stock after selling 3,269 shares during the quarter. Principal Financial Group Inc.’s holdings in Clarivate were worth $192,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in the stock. Nisa Investment Advisors LLC purchased a new position in Clarivate in the second quarter worth $26,000. Truist Financial Corp purchased a new position in Clarivate during the 2nd quarter worth $63,000. Forum Financial Management LP acquired a new position in Clarivate during the 2nd quarter valued at about $75,000. Headlands Technologies LLC raised its stake in Clarivate by 749.2% in the second quarter. Headlands Technologies LLC now owns 14,632 shares of the company’s stock valued at $83,000 after buying an additional 12,909 shares during the last quarter. Finally, Transcend Capital Advisors LLC acquired a new stake in Clarivate in the second quarter worth about $86,000. Institutional investors own 85.72% of the company’s stock.
Insiders Place Their Bets
In other news, insider Bar Veinstein sold 120,000 shares of the firm’s stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $7.00, for a total transaction of $840,000.00. Following the sale, the insider now owns 976,583 shares of the company’s stock, valued at approximately $6,836,081. This trade represents a 10.94 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Michael J. Angelakis acquired 1,500,000 shares of Clarivate stock in a transaction on Wednesday, November 20th. The stock was purchased at an average price of $5.11 per share, with a total value of $7,665,000.00. Following the purchase, the director now owns 1,500,000 shares of the company’s stock, valued at $7,665,000. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. Insiders have sold 197,646 shares of company stock valued at $1,379,111 in the last ninety days. 23.14% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
View Our Latest Research Report on Clarivate
Clarivate Price Performance
Shares of CLVT opened at $5.74 on Tuesday. The business’s 50-day moving average is $6.17 and its two-hundred day moving average is $6.11. The company has a market capitalization of $4.08 billion, a P/E ratio of -2.88 and a beta of 1.18. Clarivate Plc has a fifty-two week low of $4.25 and a fifty-two week high of $9.60. The company has a debt-to-equity ratio of 0.84, a quick ratio of 0.88 and a current ratio of 0.88.
Clarivate (NYSE:CLVT – Get Free Report) last posted its earnings results on Wednesday, November 6th. The company reported $0.19 EPS for the quarter, hitting the consensus estimate of $0.19. Clarivate had a positive return on equity of 9.69% and a negative net margin of 50.00%. The firm had revenue of $622.20 million for the quarter, compared to analyst estimates of $640.81 million. During the same period last year, the company earned $0.18 earnings per share. Clarivate’s revenue for the quarter was down 3.9% compared to the same quarter last year. Research analysts predict that Clarivate Plc will post 0.63 earnings per share for the current year.
Clarivate Company Profile
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
See Also
- Five stocks we like better than Clarivate
- What is a Special Dividend?
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Pros And Cons Of Monthly Dividend Stocks
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Industrial Products Stocks Investing
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.